Introduction: Hormone replacement therapy (HRT) and walking were investigated independently and in combination, to determine which treatment provided most effect on bone turnover in postmenopausal women.
Methods: Using a randomised double-blind pilot study, 10 subjects received HRT (transdermal estradiol, 50 μg/day and oral MPA 5 mg/day) and 12 received placebo for 20 weeks. Following a baseline period of treatment, both groups undertook a graduated walking regimen, which increased in intensity, duration and frequency parameters from weeks 8–20. Measurements of aerobic capacity, female sex hormones, bone formation markers [osteocalcin (OC) and bone alkaline phosphatase (BAP)] and bone resorption markers [deoxypyridinoline (DPD) and pyridinoline (PYR)] were measured at baseline (T1), week 8 (T2) and week 20 (T3).
Results: Age, time of postmenopause, weight or body mass index were no different between each groups. The HRT group had significantly higher estradiol levels compared with the placebo group at T2 and T3. FSH and LH levels were significantly reduced following HRT. DPD and PYR were significantly reduced from baseline levels at T2 and T3 with HRT. No significant changes occurred in OC or BAP levels with either HRT or walking. Walking did not change bone turnover markers in either the HRT or placebo group.
Conclusion: HRT reduces bone resorption, however, walking alone at the intensity and duration prescribed, or the combination of HRT and walking, provided no additional benefit after menopause. Therefore, HRT, but not walking is an effective treatment in reducing bone turnover in postmenopause women.
If the inline PDF is not rendering correctly, you can download the PDF file here.
1. Delmas PD Confavreux E Garnero P Fardellone P de Vernejoul MC Cormier C et al. A combination of low doses of 17 beta-estradiol and norethisterone acetate prevents bone loss and normalizes bone turnover in postmenopausal women. Osteoporosis international: a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA. 2000; 11: 177–87.
2. Dresner-Pollak R Parker RA Poku M Thompson J Seibel MJ Greenspan SL. Biochemical markers of bone turnover reflect femoral bone loss in elderly women. Calcified tissue international. 1996; 59: 328–33.
3. Juraschek M Seibel MJ Woitge HW Krempien B Bauss F. Association between histomorphometry and biochemical markers of bone turnover in a longitudinal rat model of parathyroid hormone-related peptide (PTHrP)-mediated tumor osteolysis. Bone. 2000; 26: 475–83.
4. Seibel MJ. Molecular markers of bone turnover: biochemical technical and analytical aspects. Osteoporosis international: a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA. 2000; 11 Suppl 6: S18–29.
5. Seibel MJ. Biochemical markers of bone turnover: part I: biochemistry and variability. The Clinical biochemist Reviews / Australian Association of Clinical Biochemists. 2005; 26: 97–122.
6. Seibel MJ. Biochemical markers of bone turnover part II: clinical applications in the management of osteoporosis. The Clinical biochemist Reviews / Australian Association of Clinical Biochemists. 2006; 27: 123–38.
7. Seibel MJ. Clinical application of biochemical markers of bone turnover. Arquivos brasileiros de endocrinologia e metabologia. 2006; 50: 603–20.
8. Seibel MJ Dunstan CR Zhou H Allan CM Handelsman DJ. Sex steroids not FSH influence bone mass. Cell. 2006; 127: 1079; author reply 80–1.
9. Woitge HW Seibel MJ. Biochemical markers to survey bone turnover. Rheumatic diseases clinics of North America. 2001; 27: 49–80.
10 Schlemmer A Hassager C Delmas PD Christiansen C. Urinary excretion of pyridinium cross-links in healthy women; the long-term effects of menopause and oestrogen/progesterone therapy. Clin Endocrinol (Oxf). 1994; 40: 777–82.
11 Rosen CJ Chesnut CH 3rd Mallinak NJ. The predictive value of biochemical markers of bone turnover for bone mineral density in early postmenopausal women treated with hormone replacement or calcium supplementation. J Clin Endocrinol Metab. 1997; 82: 1904–10.
12. Garnero P Sornay-Rendu E Chapuy MC Delmas PD. Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis. J Bone Miner Res. 1996; 11: 337–49.
13. Guthrie JR Ebeling PR Hopper JL Barrett-Connor E Dennerstein L Dudley EC et al. A prospective study of bone loss in menopausal Australian-born women. Osteoporosis international: a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA. 1998; 8: 282–90.
14. Mazzuoli G Acca M Pisani D Diacinti D Scarda A Scarnecchia L et al. Annual skeletal balance and metabolic bone marker changes in healthy early postmenopausal women: results of a prospective study. Bone. 2000; 26: 381–6.
15. Bischoff H Stahelin HB Vogt P Friderich P Vonthein R Tyndall A et al. Immobility as a major cause of bone remodeling in residents of a long-stay geriatric ward. Calcified tissue international. 1999; 64: 485–9.
16. Vico L Collet P Guignandon A Lafage-Proust MH Thomas T Rehaillia M et al. Effects of long-term microgravity exposure on cancellous and cortical weight-bearing bones of cosmonauts. Lancet. 2000; 355: 1607–11.
17. Macari S Duffles LF Queiroz-Junior CM Madeira MF Dias GJ Teixeira MM et al. Oestrogen regulates bone resorption and cytokine production in the maxillae of female mice. Archives of oral biology. 2015; 60: 333–41.
18. Westerlind KC Wronski TJ Ritman EL Luo ZP An KN Bell NH et al. Estrogen regulates the rate of bone turnover but bone balance in ovariectomized rats is modulated by prevailing mechanical strain. Proc Natl Acad Sci U S A. 1997; 94: 4199–204.
19. Prior JC Vigna YM Wark JD Eyre DR Lentle BC Li DK et al. Premenopausal ovariectomy-related bone loss: a randomized double-blind one-year trial of conjugated estrogen or medroxyprogesterone acetate. J Bone Miner Res. 1997; 12: 1851–63.
20. Jilka RL Hangoc G Girasole G Passeri G Williams DC Abrams JS et al. Increased osteoclast development after estrogen loss: mediation by interleukin-6. Science. 1992; 257: 88–91.
21. Kameda T Mano H Yuasa T Mori Y Miyazawa K Shiokawa M et al. Estrogen inhibits bone resorption by directly inducing apoptosis of the bone-resorbing osteoclasts. The Journal of experimental medicine. 1997; 186: 489–95.
22. Horowitz MC. Cytokines and estrogen in bone: antiosteoporotic effects. Science.1993; 260: 626–7.
23. Passeri G Girasole G Jilka RL Manolagas SC. Increased interleukin-6 production by murine bone marrow and bone cells after estrogen withdrawal. Endocrinology. 1993; 133: 822–8.
24. Ralston SH Ho LP Helfrich MH Grabowski PS Johnston PW Benjamin N. Nitric oxide: a cytokine-induced regulator of bone resorption. J Bone Miner Res. 1995; 10: 1040–9.
25. Ray A Prefontaine KE Ray P. Down-modulation of interleukin-6 gene expression by 17 beta-estradiol in the absence of high affinity DNA binding by the estrogen receptor. J Biol Chem. 1994; 269: 12940–6.
26. Pottratz ST Bellido T Mocharla H Crabb D Manolagas SC. 17 beta-Estradiol inhibits expression of human interleukin-6 promoter-reporter constructs by a receptor-dependent mechanism. J Clin Invest. 1994; 93: 944–50.
27. Turner CH Takano Y Owan I Murrell GA. Nitric oxide inhibitor L-NAME suppresses mechanically induced bone formation in rats. Am J Physiol. 1996; 270: E634–9.
28. Adami S Gatti D Braga V Bianchini D Rossini M. Site-specific effects of strength training on bone structure and geometry of ultradistal radius in postmenopausal women. J Bone Miner Res. 1999; 14: 120–4.
29. Haapasalo H Kannus P Sievanen H Pasanen M Uusi-Rasi K Heinonen A et al. Effect of long-term unilateral activity on bone mineral density of female junior tennis players. J Bone Miner Res. 1998; 13: 310–9.
30. Huddleston AL Rockwell D Kulund DN Harrison RB. Bone mass in lifetime tennis athletes. Jama. 1980; 244: 1107–9.
31. Jones HH Priest JD Hayes WC Tichenor CC Nagel DA. Humeral hypertrophy in response to exercise. J Bone Joint Surg Am. 1977; 59: 204–8.
32. Kannus P Haapasalo H Sievanen H Oja P Vuori I. The site-specific effects of long-term unilateral activity on bone mineral density and content. Bone. 1994; 15: 279–84.
33. Kohrt WM Snead DB Slatopolsky E Birge SJ Jr. Additive effects of weight-bearing exercise and estrogen on bone mineral density in older women. J Bone Miner Res. 1995; 10: 1303–11.
34. Heikkinen J Kyllonen E Kurttila-Matero E Wilen-Rosenqvist G Lankinen KS Rita H et al. HRT and exercise: effects on bone density muscle strength and lipid metabolism. A placebo controlled 2-year prospective trial on two estrogen-progestin regimens in healthy postmenopausal women. Maturitas. 1997; 26: 139–49.
35. Humphries B Newton RU Bronks R Marshall S McBride J Triplett-McBride T et al. Effect of exercise intensity on bone density strength and calcium turnover in older women. Med Sci Sports Exerc. 2000; 32: 1043–50.
36. Nelson ME Fiatarone MA Morganti CM Trice I Greenberg RA Evans WJ. Effects of high-intensity strength training on multiple risk factors for osteoporotic fractures. A randomized controlled trial. Jama. 1994; 272: 1909–14.
37. Pruitt LA Taaffe DR Marcus R. Effects of a one-year high-intensity versus low-intensity resistance training program on bone mineral density in older women. J Bone Miner Res. 1995; 10: 1788–95.
38. Chamay A Tschantz P. Mechanical influences in bone remodeling. Experimental research on Wolff's law. J Biomech. 1972; 5: 173–80.
39. Ito M Nakamura T Ikeda S Tahara Y Hashmi R Tsurusaki K et al. Effects of lifetime volleyball exercise on bone mineral densities in lumbar spine calcaneus and tibia for pre- peri- and postmenopausal women. Osteoporosis international: a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA. 2001; 12: 104–11.
40. Coupland CA Cliffe SJ Bassey EJ Grainge MJ Hosking DJ Chilvers CE. Habitual physical activity and bone mineral density in postmenopausal women in England. Int J Epidemiol. 1999; 28: 241–6.
41. Welsh L Rutherford OM. Hip bone mineral density is improved by high-impact aerobic exercise in postmenopausal women and men over 50 years. Eur J Appl Physiol Occup Physiol. 1996; 74: 511–7.
42. Chow R Harrison JE Notarius C. Effect of two randomised exercise programmes on bone mass of healthy postmenopausal women. Br Med J (Clin Res Ed). 1987; 295: 1441–4.
43. Snow CM Shaw JM Winters KM Witzke KA. Long-term exercise using weighted vests prevents hip bone loss in postmenopausal women. J Gerontol A Biol Sci Med Sci. 2000; 55: M489–91.
44. Moreira LD Fronza FC Dos Santos RN Zach PL Kunii IS Hayashi LF et al. The benefits of a high-intensity aquatic exercise program (HydrOS) for bone metabolism and bone mass of postmenopausal women. Journal of bone and mineral metabolism. 2014; 32: 411–9.
45. Moreira LD Oliveira ML Lirani-Galvao AP Marin-Mio RV Santos RN Lazaretti-Castro M. Physical exercise and osteoporosis: effects of different types of exercises on bone and physical function of postmenopausal women. Arquivos brasileiros de endocrinologia e metabologia. 2014; 58: 514–22.
46. Kerr D Ackland T Maslen B Morton A Prince R. Resistance training over 2 years increases bone mass in calcium-replete postmenopausal women. J Bone Miner Res. 2001; 16: 175–81.
47. Ryan AS Treuth MS Hunter GR Elahi D. Resistive training maintains bone mineraldensityin postmenopausal women. Calcified tissue international. 1998; 62: 295–9.
48. Cardinale M Pope MH. The effects of whole body vibration on humans: dangerous or advantageous? Acta physiologica Hungarica. 2003; 90: 195–206.
49. Weber-Rajek M Mieszkowski J Niespodzinski B Ciechanowska K. Whole-body vibration exercise in postmenopausal osteoporosis. Przeglad menopauzalny = Menopause review. 2015; 14: 41–7.
50. Tankisheva E Bogaerts A Boonen S Delecluse C Jansen P Verschueren SM. Effects of a Six-Month Local Vibration Training on Bone Density Muscle Strength Muscle Mass and Physical Performance in Postmenopausal Women. Journal of strength and conditioning research / National Strength & Conditioning Association. 2015; 29: 2613–22.
51. Tankisheva E Bogaerts A Boonen S Feys H Verschueren S. Effects of intensive whole-body vibration training on muscle strength and balance in adults with chronic stroke: a randomized controlled pilot study. Archives of physical medicine and rehabilitation. 2014; 95: 439–46.
52. Notelovitz M Martin D Tesar R Khan FY Probart C Fields C et al. Estrogen therapy and variable-resistance weight training increase bone mineral in surgically menopausal women. J Bone Miner Res. 1991; 6: 583–90.